EUVIMEDEUVIMED entdecken
Fallbericht

Ribavirin Therapy for Hepatitis E Virus-Induced Acute on Chronic Liver Failure: A Preliminary Report

Rohit Goyal, Ajay Kumar, Subrat K Panda, Shashi B Paul, Subrat K Acharya

Antiviral Therapy · 2012-08 · 17 (6) · 1091-1096

DOI: 10.3851/imp2317 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Antiviral Therapy, online erschienen am 01.08.2012. Verfasst von Rohit Goyal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis E virus (HEV) is a common cause of acute on chronic liver failure (ACLF) in HEV hyperendemic regions with high mortality. Treatment for HEV-induced ACLF is currently not available. Recently, efficacy of ribavirin in genotype 3 chronic hepatitis E patients has been reported; however, whether ribavirin is effective in genotype 1 HEV infection is not yet known. The present study includes four patients with HEV-induced ACLF treated with ribavirin in a genotype 1 HEV hyperendemic region. Diagnosis of ACLF was made by conventional criteria and HEV as the cause of ACLF was confirmed by detection of HEV RNA by reverse transcriptase PCR. Ribavirin dose ranged from 200 to 600 mg/day and was used for a median duration of 12 (range 3–24) weeks. All patients had undetectable HEV in 3–8 weeks, survived and none had serious adverse effects. This preliminary observation from a single centre indicates that ribavirin may be an effective therapeutic agent for HEV-induced ACLF and a randomized control trial is needed to establish its efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdolescentAntiviral AgentsEnd Stage Liver DiseaseFemaleGenotypeHepatitis EHepatitis E virusHumansLiver Failure, AcuteMaleMiddle AgedRNA, ViralReverse Transcriptase Polymerase Chain ReactionRibavirinTreatment Outcome

Substanzen

Antiviral AgentsRNA, ViralRibavirin

Autor:innen und Institutionen

  • Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India.

Zitieren

APA

Goyal, R., Kumar, A., Panda, S. K., Paul, S. B., & Acharya, S. K. (2012). Ribavirin Therapy for Hepatitis E Virus-Induced Acute on Chronic Liver Failure: A Preliminary Report. Antiviral Therapy, 17(6), 1091-1096. https://doi.org/10.3851/imp2317

Vancouver

Goyal R, Kumar A, Panda SK, Paul SB, Acharya SK. Ribavirin Therapy for Hepatitis E Virus-Induced Acute on Chronic Liver Failure: A Preliminary Report. Antiviral Therapy. 2012;17(6):1091-1096. doi:10.3851/imp2317

BibTeX
@article{Goyal2012,
  author = {Goyal, Rohit and Kumar, Ajay and Panda, Subrat K and Paul, Shashi B and Acharya, Subrat K},
  title = {Ribavirin Therapy for Hepatitis E Virus-Induced Acute on Chronic Liver Failure: A Preliminary Report},
  journal = {Antiviral Therapy},
  year = {2012},
  volume = {17},
  number = {6},
  pages = {1091--1096},
  doi = {10.3851/imp2317}
}
Kostenlos starten →